Browse > Article
http://dx.doi.org/10.3345/kjp.2007.50.12.1231

The clinical manifestations, the short- and long-term outcomes of Bartter syndrome  

Park, Hye Won (Departments of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine)
Lee, Joo Hoon (Departments of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine)
Park, Young Seo (Departments of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.12, 2007 , pp. 1231-1240 More about this Journal
Abstract
Purpose : Bartter syndrome is a renal tubular defect in electrolyte transport characterized by hypokalemia, metabolic alkalosis and other clinical signs and symptoms. The aims of this study were to analyze the clinical manifestations and the short- and long-term outcomes of Bartter syndrome. Methods : We retrospectively reviewed clinical history, laboratory finding of blood and urine, renal ultrasonography, and hearing tests of five patients who were diagnosed and managed with Bartter syndrome at Asan Medical Center from April 1992 to May 2007. We also evaluated height and body weight periodically after institution of therapy. Results : All patients had poor oral intake, failure to thrive and polyuria. Three of them had maternal history of polyhydramnios and premature delivery. The mean age at diagnosis was 11.8 months. All children presented with hypokalemia, metabolic alkalosis, hyperreninemia. Their blood pressures were normal. One patient had nephrocalcinosis on renal ultrasonography and all of them had normal result in hearing tests. After treatment with indomethacin or other prostaglandin inhibitors and potassium supplementation,their clinical features improved with catch-up growth and improvement in the development during long-term follow-up. Conclusion : We emphasize that early diagnosis and proper treatment in patient with Bartter syndrome are related to better prognosis.
Keywords
Bartter syndrome; Failure to thrive; Growth; Treatment outcome;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis, a new syndrome. Am J Med 1962;33: 811-28   DOI
2 Barbour GL, Day JO. Asymptomatic Bartter's syndrome. South Med J 1978;71:1341-4   DOI   ScienceOn
3 Reinalter SC, Jeck N, Brochhausen C, Watzer B, Nüsing RM, Seyberth HW, et al. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 2002;62:253-60   DOI   ScienceOn
4 Mourani CC, Sanjad SA, Akatcherian CY. Bartter syndrome in a neonate: early treatment with indomethacin. Pediatr Nephrol 2000;14:143-5   DOI
5 Littlewood JM, Lee MR, Meadow SR. Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors. Arch Dis Child 1978;53:43-8   DOI   ScienceOn
6 Proesmans W, Massa G, Vanderschueren-Lodeweyckx M. Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome. Pediatr Nephrol 1988;2:205-9   DOI
7 Komhoff M, Tekesin I, Peters M, Leonhard A, Seyberth HW. Perinatal management of a preterm neonate affected by hyperprostaglandin E2 syndrome(HPS). Acta Paediatr 2005; 94:1690-3   DOI   ScienceOn
8 Lee KY, Cho BS, Lee HY, Bernstein J. A case of Bartter's syndrome. J Korean Pediatr Soc 1991;34:849-56
9 Goodman AD, Vagnucci AH, Hartroft PM. Pathogenesis of Bartter's syndrome. N Engl J Med 1969;281:1435-9   DOI   ScienceOn
10 Seidel C, Reinalter S, Seyberth HW, Scharer K. Pre-pubertal growth in the hyperprostaglandin E syndrome. Pediatr Nephrol 1995;9:723-8   DOI
11 Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the $K^+$ channel ROMK. Nat Genet 1996;14:152-6   DOI   ScienceOn
12 Dane B, Yayla M, Dane C, Cetin A. Prenatal diagnosis of Bartter syndrome with biochemical examination of amniotic fluid: case report. Fetal Diagn Ther 2007;22:206-8   DOI   ScienceOn
13 Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997;17:171-8   DOI   ScienceOn
14 Komhoff M, Jeck ND, Seyberth HW, Grone HJ, Nusing RM, Brever MD. Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter- like syndrome. Kidney Int 2000;58:2420-4   DOI   ScienceOn
15 Rodriguez-Soriano J. Bartter and related syndromes: the puzzle is almost solved. Pediatr Nephrol 1998;12:315-27   DOI
16 Han JS, Chang SH, Lee JS. Clinical usefulness of transtubular potassium gradient(TTKG) and urine ammonium in differential diagnosis of hypokalemia. Korean J Nephrol 1997; 16:417-25
17 Norby L, Flamenbaum W, Lentz R, Ramwell P. Prostaglandins and aspirin therapy in Bartter's syndrome. The Lancet 1976;18:604-6
18 Ryu JM, Lee JH, Han HW, Park YS. A case of neonatal bartter syndrome. J Korean Soc Pediatr Nephrol 2005;9:255-62
19 Yoon JH, Kwon JE, Lee JO, Lee SG. A case of Bartter's syndrome. J Korean Pediatr Soc 1993;36:1308-14
20 Simon DB, Karet FE, Hamdan JM, Dipietro A, Sanjad S, Lifton RP. Bartter's syndrome, hypokalemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl co-transporter NKCC2. Nat Genet 1996;13:183-8   DOI   ScienceOn
21 Bowden RE, Gil JR, Radfar N, Taylor AA, Keiser HR. Prostaglandin synthetase inhibitors in Bartter's syndrome. JAMA 1978;239:117-21   DOI
22 Song JS, Shinn JJ, You KH, Lee HK, Cha WK, Kwon KH, et al. A case of Bartter's syndrome in an adult. Korean J Nephrol 1997;16:567-71
23 Sieck UV, Ohlsson A. Fetal polyuria and hydramnios associated with Bartter's syndrome. Obstet Gynecol 1984;63: 22S-24S
24 Cumming WA, Ohlsson A. Nephrocalcinosis in Bartter's syndrome: demonstration by ultrasonography. Pediatr Radiol 1984;14:125-6   DOI
25 Schlingmann KP, Konrad M, Seyberth HW. Genetics of hereditary disorders of magnesium homeostasis. Pediatr Nephrol 2004;19:13-25   DOI
26 Cho YS, Yoon YH, Chae BN, Choi CY, Yi KH, Kim YG, et al. Pseudo-Bartter's syndrome with nephrocalcinosis caused by long-term surreptitious furosemide ingestion. Korean J Med 1993;45:255-60
27 Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D. Bartter's and Gitelman's Syndromes: from gene to clinic. Nephron Physiol 2004;96:65-78   DOI   ScienceOn
28 Proesmans W, Devlieger H, Van Assche A, Eqqermont E, Vandenberqhe K, Lemmens F, et al. Bartter's syndrome in two siblings-Antenatal and neonatal observations. Int J Pediatr Nephrol 1985;6:63-70
29 Rodrigues Pereira R, Hasaart T. Hydramnios and observations in Bartter's syndrome. Acta Obstet Gynecol Scand 1982;61:477-8   DOI   ScienceOn
30 Fichman MP, Telfer N, Zia P, Speckart P, Golub M, Rude R. Role of prostaglandins in the pathogenesis of Bartter's syndrome. Am J Med 1976;60:785-97   DOI   ScienceOn
31 Mackie FE, Hodson EM, Roy LP, Knight JF. Neonatal Bartter syndrome-use of indomethacin in the newborn period and prevention of growth failure. Peditr Nephrol 1996;10:756-8   DOI
32 Mastumoto J, Han BK, Restrepo de Rovetto C, Welch TR. Hypercalciuric Bartter syndrome: resolution of nephrocalcinosis with indomethacin. AJR 1989;152:1251-3   DOI   ScienceOn
33 Lee HY, Chyung YS, Ahn KJ, Lee SW, Kim MR, Kim YK, et al. A case of Bartter's syndrome in an adult. Korean J Med 1991;40:844-52
34 Donker AJ, de Jong PE, van Eps LW, Brentjens JR, Barkker K. Doorenbos H. Indomethacin in Bartter's syndrome: dose the syndrome represent a state of hyperprostaglandinism? Nephron 1977;19:200-13   DOI
35 Kim IS, Kang JH, Shin YH, Lee DK, Kim SN, Pai KS. A case of Bartter syndrome with muscle weakness and short stature. J Korean Soc Pediatr Nephrol 2002;6:259-65   과학기술학회마을
36 Proesmans W. Bartter syndrome and its neonatal variant. Eur J Pediatr 1997;156:669-79   DOI
37 Lechacz G, Arbus G, Balfe JW, Wolff ED, Robson L. Effect of ibuprofen on growth in a child with Bartter syndrome. J Pediatr 1979;95:319-20   DOI